Anti-myelin oligodendrocyte glycoprotein and human leukocyte antigens as markers in pediatric and adolescent multiple sclerosis: on diagnosis, clinical phenotypes, and therapeutic responses

HIGHLIGHTS

• who: Therapeutic Responses from the Immunogenetics Laboratory of, st Department of Neurology, Medical School of National and Kapodistrian University of Athens, Aeginition Hospital, Athens, Greece have published the research: Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic Responses, in the Journal: Multiple Sclerosis International of 22/Nov/2018
• what: HLA alleles and MOG antibodies have emerged as two major biomarkers of pediatric and adolescent MS and related demyelinating disorders.
• how: Earlier studies investigated MOG autoimmunity within the framework of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.